| Khurem Farooq |
Currently, Khurem Farooq is Chief Executive Officer & Director at Gyroscope Therapeutics Ltd. and Chief Executive Officer & Director at Gyroscope Therapeutics Holdings Plc. He is also on the board of Orbit Biomedical Ltd.
He previously held the position of Vice President-Global Product Strategy at Genentech, Inc.
Mr. Farooq received an undergraduate degree from the University of Wolverhampton and a graduate degree from the University of Aston. |
| Christopher John Hollowood |
Christopher John Hollowood is a British businessperson who founded Freeline Therapeutics Ltd. and who has been at the head of 5 different companies. Presently, he is Chairman of Freeline Therapeutics Ltd., Chairman of Gyroscope Therapeutics Ltd., Chairman for SwanBio Therapeutics, Inc., Chairman of Gyroscope Therapeutics Holdings Plc, Chief Investment Officer of Syncona Partners LLP and Chief Investment Officer at Syncona Investment Management Ltd. Christopher John Hollowood is also on the board of Swanbio Therapeutics Ltd., Freeline Therapeutics Holdings Plc and Purespring Therapeutics Ltd.
Dr. Hollowood previously was Chairman of Nightstar Therapeutics Ltd., Managing Partner at Syncona Ltd. and Partner at Apposite Capital LLP.
Dr. Hollowood received a doctorate from the University of Cambridge. |
| Jane Hughes |
Jane Hughes holds the position of Chief Scientific Officer at Gyroscope Therapeutics Holdings Plc.
In the past she held the position of Director-Discovery Medicine & Immuno Inflammation at GlaxoSmithKline Plc and Senior Director-Integrated Drug Discovery at Charles River Laboratories, Inc.
She received a doctorate from Keele University. |
| Edward Lang |
Edward Lang is Chief Business Officer for Gyroscope Therapeutics Holdings Plc.
He previously held the position of Vice President-Corporate Affairs at Juno Therapeutics, Inc.
He received an undergraduate degree from LaSalle University. |
| Jessica Stitt |
Currently, Jessica Stitt holds the position of Chief Financial Officer for Gyroscope Therapeutics Holdings Plc.
Ms. Stitt previously was Vice President-Finance & Investor Relations at Theravance Biopharma, Inc. and Vice President-Finance & Operations at MyoKardia, Inc.
Ms. Stitt received an undergraduate degree from St. Anselm College and an MBA from Simmons School of Management. |
| Nadia Waheed |
Nadia Waheed is Chief Medical Officer for Gyroscope Therapeutics Holdings Plc.
Dr. Waheed received a graduate degree from Harvard T.H. Chan School of Public Health and a doctorate from Aga Khan University. |
